Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Sponsor
University of California, Irvine
Study ID
NCT00667472
Phase
PHASE1
Status
Withdrawn

Conditions

  • Port-Wine Stain

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ranibizumab — DRUG
    Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks
  • Pulsed Dye Laser — DEVICE
    Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Study Details

The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser therapy and topical ranibizumab will improve port wine stain therapeutic outcome.

Key Dates

First listed
Apr 28, 2008
Start date
Mar 31, 2008
Status verified
Oct 2022
Primary completion
Nov 30, 2013
Completion
Nov 30, 2013

Study Design

Enrollment
0 participants (actual)
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Ranibizumab
    Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks
  • Experimental: Pulsed Dye Laser
    Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

Primary Outcome Measure

Port Wine Stain response to laser treatment [ Time Frame: 8 weeks ]

Related Studies